Glatiramer acetate for the treatment of multiple sclerosis

By Wolinsky Jerry S  

Expert Opinion on Pharmacotherapy, Vol. 5, Iss. 4, 2004-04 ,pp. : 875-891

Informa Healthcare

Access to resources Recommend Favorite

The pharmacokinetics of glatiramer acetate for multiple sclerosis treatment

By Messina Silvia   Patti Francesco  

Expert Opinion on Drug Metabolism and Toxicology, Vol. 9, Iss. 10, 2013-10 ,pp. : 1349-1359

Informa Healthcare

Access to resources Recommend Favorite

Risk-Benefit Assessment of Glatiramer Acetate in Multiple Sclerosis

By Ziemssen T.  

Drug Safety, Vol. 24, Iss. 13, 2001-01 ,pp. : 979-990

Adis International

Access to resources Recommend Favorite

Allelic combinations of immune-response genes associated with glatiramer acetate treatment response in Russian multiple sclerosis patients

By Tsareva Ekaterina Y   Kulakova Olga G   Boyko Alexey N   Shchur Sergey G   Lvovs Dmitrijs   Favorov Alexander V   Gusev Evgeny I   Vandenbroeck Koen   Favorova Olga O  

Pharmacogenomics, Vol. 13, Iss. 1, 2012-01 ,pp. : 43-53

Future Medicine

Access to resources Recommend Favorite

Glatiramer Acetate in the Treatment of Multiple Sclerosis: Emerging Concepts Regarding its Mechanism of Action

By Lalive Patrice H.   Neuhaus Oliver  

CNS Drugs, Vol. 25, Iss. 5, 2011-05 ,pp. : 401-414

Adis International

Access to resources Recommend Favorite